Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    Idiopathic Pulmonary Fibrosis | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
2 Recruiting Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
Condition: Ambulatory IPF
Interventions: Drug: Rituximab;   Drug: Placebo
3 Recruiting Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Hyperpolarized 129-Xenon gas;   Device: MRI
4 Recruiting The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Interstitial Pneumonitis;   Desquamative Interstitial Pneumonia
Interventions: Other: Aerobic Exercise Training;   Other: Education
5 Recruiting Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease
Conditions: Pulmonary Fibrosis;   Lung Disease
Intervention:
6 Recruiting Cromolyn Detection of Silent Aspiration
Conditions: Gastroesophageal Reflux;   Respiratory Aspiration;   Idiopathic Pulmonary Fibrosis;   Lung Transplantation
Intervention: Drug: Cromolyn Sodium
7 Recruiting Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens
Conditions: Pregnancy;   Sexually Transmitted Diseases
Interventions: Behavioral: Interactive multimedia platform;   Behavioral: Intervention arm counseling;   Behavioral: Standard of care counseling
8 Recruiting The Six Minute Walk Test: Influence of Patient Effort on Results and Interpretation
Condition: Each Patient Serves as His/Her Own Control.
Intervention: Behavioral: alternative instruction in exercise testing (6MWT)
9 Recruiting Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
Condition: BRAF V600E Mutation
Interventions: Drug: Dabrafenib Mesylate;   Drug: Trametinib Dimethyl Sulfoxide
10 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
Intervention:

Study has passed its completion date and status has not been verified in more than two years.